DOC - Healthpeak Q1 - The Best In The Space With A 15% Upside
2024-05-14 11:45:30 ET
Summary
- Healthpeak (DOC) is an attractive healthcare REIT with a diverse portfolio and a yield of over 7%.
- The company is unlikely to see significant near-term AFFO growth, but offers stability and potential slight growth.
- The stock is currently undervalued and has a conservative double-digit upside, making it a good buy.
Dear subscribers,
Some continue to be dubious about investing in a REIT like Healthpeak ( DOC ), which I have been purchasing for the past 6 months, at prices below $17/share, which has led me to my current cost basis for the company of well below $17.5/share and a yield of over 7% for this BBB-rated equivalent REIT.
With its diverse portfolio of life science properties, outpatient medical care facilities, and continuing care retirement communities, it has a very interesting mix of assets, and is one of the more interesting healthcare REIT plays that we can see here....
Healthpeak Q1 - The "Best" In The Space With A 15% Upside